Abstract
Myelodysplastic Syndromes, a heterogeneous group of hematological disorders, are characterized by abnormalities in phosphoinositide-dependent signaling, epigenetic regulators, apoptosis, and cytokine interactions within the bone marrow microenvironment, contributing to disease pathogenesis and neoplastic growth. Comprehensive knowledge of these pathways is crucial for the development of innovative therapies that aim to restore normal apoptosis and improve patient outcomes.
| Original language | English |
|---|---|
| Article number | 101014 |
| Number of pages | 8 |
| Journal | Advances in Biological Regulation |
| Volume | 91 |
| DOIs | |
| Publication status | Published - Jan 2024 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Acute myeloid leukemia
- Apoptosis
- Cytokines secretion
- Epigenetic regulation
- Myelodysplastic Syndromes
- Phosphoinositide signaling
Fingerprint
Dive into the research topics of 'Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progression'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver